These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 24675495

  • 1. Clinico-pathological study of K-ras mutations in colorectal tumors in Saudi Arabia.
    Zahrani A, Kandil M, Badar T, Abdelsalam M, Al-Faiar A, Ismail A.
    Tumori; 2014; 100(1):75-9. PubMed ID: 24675495
    [Abstract] [Full Text] [Related]

  • 2. Clinico-Pathological Study of K-ras Mutations in Colorectal Tumors: A Single-Center Retrospective Study of 51 Patients in Madinah, Saudi Arabia.
    Mulla N, Alshareef A, Syed AR, Al-Jahel M.
    Cureus; 2020 Aug 24; 12(8):e9978. PubMed ID: 32983680
    [Abstract] [Full Text] [Related]

  • 3. [Frequency and clinicopathological associations of K-ras mutations in Venezuelan patients with colo-rectal cancer].
    Estrada P, Rojas-Atencio A, Zabala W, Borjas L, Soca L, Urdaneta K, Alvarez-Nava F, Cañizales J, Rojas J, Soto M.
    Invest Clin; 2009 Mar 24; 50(1):55-63. PubMed ID: 19418727
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
    Zlobec I, Bihl MP, Schwarb H, Terracciano L, Lugli A.
    Int J Cancer; 2010 Jul 15; 127(2):367-80. PubMed ID: 19908233
    [Abstract] [Full Text] [Related]

  • 5. [Detection of KRAS gene mutation and its clinical significance in colorectal adenocarcinoma].
    Xu C, Liu YL, Huang J, He DM, Hou YY, Ji Y, Hou J, Lu SH, Xu JF, Hu Q, Shi Y, Zhao LJ, Tan YS.
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct 15; 41(10):667-70. PubMed ID: 23302307
    [Abstract] [Full Text] [Related]

  • 6. [The frequency and spectrum of KRAS mutations in metastatic colorectal cancer].
    Mazurenko NN, Gagarin IM, Tsyganova IV, Mochal'nikova VV, Breder VV.
    Vopr Onkol; 2013 Oct 15; 59(6):751-5. PubMed ID: 24624786
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J, Bavi P, Al-Haqawi W, Sultana M, Al-Harbi S, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Uddin S, Al-Kuraya KS.
    J Pathol; 2009 Dec 15; 219(4):435-45. PubMed ID: 19824059
    [Abstract] [Full Text] [Related]

  • 9. Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.
    Neumann J, Zeindl-Eberhart E, Kirchner T, Jung A.
    Pathol Res Pract; 2009 Dec 15; 205(12):858-62. PubMed ID: 19679400
    [Abstract] [Full Text] [Related]

  • 10. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
    Kusaka T, Fukui H, Sano Y, Ueda Y, Chiba T, Fujimori T.
    J Gastroenterol Hepatol; 2000 Oct 15; 15(10):1151-7. PubMed ID: 11106095
    [Abstract] [Full Text] [Related]

  • 11. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
    Bazan V, Migliavacca M, Zanna I, Tubiolo C, Grassi N, Latteri MA, La Farina M, Albanese I, Dardanoni G, Salerno S, Tomasino RM, Labianca R, Gebbia N, Russo A.
    Ann Oncol; 2002 Sep 15; 13(9):1438-46. PubMed ID: 12196370
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mutations in codons 12 and 13 of K-ras exon 2 in colorectal tumors of Saudi Arabian patients: frequency, clincopathological associations, and clinical outcomes.
    Zekri J, Al-Shehri A, Mahrous M, Al-Rehaily S, Darwish T, Bassi S, El Taani H, Al Zahrani A, Elsamany S, Al-Maghrabi J, Sadiq BB.
    Genet Mol Res; 2017 Feb 16; 16(1):. PubMed ID: 28218784
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases.
    Karkouche R, Bachet JB, Sandrini J, Mitry E, Penna C, Côté JF, Blons H, Penault-Llorca F, Rougier P, Saint André JP, Emile JF.
    Eur J Gastroenterol Hepatol; 2012 Dec 16; 24(12):1430-7. PubMed ID: 23114745
    [Abstract] [Full Text] [Related]

  • 16. [KRAS gene mutation in colorectal cancer].
    Roa I, Sánchez T, Majlis A, Schalper K.
    Rev Med Chil; 2013 Sep 16; 141(9):1166-72. PubMed ID: 24522420
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is K-ras gene mutation a prognostic factor for colorectal cancer: a systematic review and meta-analysis.
    Ren J, Li G, Ge J, Li X, Zhao Y.
    Dis Colon Rectum; 2012 Aug 16; 55(8):913-23. PubMed ID: 22810479
    [Abstract] [Full Text] [Related]

  • 19. Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer.
    Bennani B, Gilles S, Fina F, Nanni I, Ibrahimi SA, Riffi AA, Nejjari C, Benajeh DA, El Abkari M, Martin PM, Ouafik L.
    Int J Biol Markers; 2010 Aug 16; 25(4):179-84. PubMed ID: 21161938
    [Abstract] [Full Text] [Related]

  • 20. [KRAS gene somatic mutations in Chilean patients with colorectal cancer].
    Hurtado C, Encina G, Wielandt AM, Zárate AJ, Castro M, Carrillo K, Kronberg U, López-Köstner F.
    Rev Med Chil; 2014 Nov 16; 142(11):1407-14. PubMed ID: 25694286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.